Summary
- JPMorgan International Research Enhanced Equity ETF is an active ETF seeking to outperform the MSCI EAFE Index with similar risk.
- It closely tracks the benchmark in sector/country allocations, fundamentals, volatility, and historical returns.
- Despite active management, JIRE’s performance edge is minimal, but its cost advantage over EFA supports its use as a core EAFE equity holding.
- Quantitative Risk & Value members get exclusive access to our real-world portfolio. See all our investments here »
asbe/iStock via Getty Images
Fast Facts
JPMorgan International Research Enhanced Equity ETF (JIRE) is an actively managed fund listed on 06/10/2022 with an objective of long-term capital appreciation. JIRE has a portfolio of 209 stocks, a 12-month yield of 2.97%, a 30-day
This article was written by
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Source: JIRE: A Decent Core ETF, But No Proven Edge Over Its Benchmark – Read full article at Seeking Alpha